BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 1831247)

  • 1. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
    Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
    Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin stimulates the release of oxytocin in lactating rats: evidence for a physiological role via an action at the neural lobe.
    Parker SL; Armstrong WE; Sladek CD; Grosvenor CE; Crowley WR
    Neuroendocrinology; 1991 May; 53(5):503-10. PubMed ID: 1883415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for stimulatory noradrenergic and inhibitory dopaminergic regulation of oxytocin release in the lactating rat.
    Crowley WR; Shyr SW; Kacsoh B; Grosvenor CE
    Endocrinology; 1987 Jul; 121(1):14-20. PubMed ID: 3109879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential actions of dopamine receptor subtypes on gonadotropin and growth hormone release in vitro in goldfish.
    Chang JP; Yu KL; Wong AO; Peter RE
    Neuroendocrinology; 1990 Jun; 51(6):664-74. PubMed ID: 2141920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
    Wong AO; Chang JP; Peter RE
    Endocrinology; 1992 Mar; 130(3):1201-10. PubMed ID: 1347006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of central D-1 dopamine receptors stimulates oxytocin release in the lactating rat: evidence for involvement of the hypothalamic paraventricular and supraoptic nuclei.
    Parker SL; Crowley WR
    Neuroendocrinology; 1992 Sep; 56(3):385-92. PubMed ID: 1436376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF
    Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Mogg RJ; Samson WK
    Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.
    Jackisch R; Moll S; Feuerstein TJ; Hertting G
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):105-13. PubMed ID: 2995843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
    Burris TP; Stringer LC; Freeman ME
    Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by fenoldopam (SKF 82526) and bromocriptine of the electrically evoked release of vasopressin from the rat neurohypophysis. Effects of dopamine depletion.
    Racké K; Meuresch J; Trapp B; Muscholl E
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):332-7. PubMed ID: 2874500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic regulation of the GT1 gonadotropin-releasing hormone (GnRH) neuronal cell lines: stimulation of GnRH release via D1-receptors positively coupled to adenylate cyclase.
    Martínez de la Escalera G; Gallo F; Choi AL; Weiner RI
    Endocrinology; 1992 Dec; 131(6):2965-71. PubMed ID: 1280208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
    Suarez-Roca H; Lovenberg T; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement.
    Calabresi P; Mercuri N; Stanzione P; Stefani A; Bernardi G
    Neuroscience; 1987 Mar; 20(3):757-71. PubMed ID: 2955246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of dopamine D1 receptors in the control of growth hormone secretion in the rat.
    Bluet-Pajot MT; Mounier F; Durand D; Kordon C
    J Endocrinol; 1990 Nov; 127(2):191-6. PubMed ID: 2250145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M
    J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE; Howard SG
    Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.